covid-19-astrazeneca-vaccine-policy-statement-clinical-criteria-guidance-25feb2022

Page 8

AstraZeneca Contraindications Contraindication to receiving the AstraZeneca Vaccine 1

Hypersensitivity to the following active substance or to any of the excipients: •

L-Histidine

L-Histidine hydrochloride monohydrate

Magnesium chloride hexahydrate

Polysorbate 80

Ethanol

Sucrose

Sodium chloride

Disodium edetate dihydrate (EDTA)

Water for injection

2

Consumers who have experienced major venous and/or arterial thrombosis in combination with thrombocytopenia following vaccination with any COVID-19 vaccine.

3

Consumers who have previously experienced episodes of capillary leak syndrome. Note: Very rare cases of capillary leak syndrome have been reported in the first days after receiving AstraZeneca, therefore, individuals with a known history of capillary leak syndrome should not be vaccinated with AstraZeneca.

Page 8 of 16


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
covid-19-astrazeneca-vaccine-policy-statement-clinical-criteria-guidance-25feb2022 by WBOP PHO - Issuu